Gastroesophageal reflux disease and irritable bowel syndrome: A common overlap syndrome

Current Gastroenterology Reports

Volumn 8, Issue 4, 2006, Pages 261-265

  Dickman, Ram ^b   Feroze, Hussain ^b   Fass, Ronnie ^a  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; DRUG TREATMENT FAILURE; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERALGESIA; IRRITABLE COLON; PATHOPHYSIOLOGY; PREVALENCE; REFLUX ESOPHAGITIS; REVIEW; STOMACH FUNDOPLICATION; SYMPTOMATOLOGY; TREATMENT RESPONSE;

DIAGNOSIS, DIFFERENTIAL; GASTROESOPHAGEAL REFLUX; HUMANS; IRRITABLE BOWEL SYNDROME; PREVALENCE;

EID: 33746909767     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-006-0045-1     Document Type: Review

References (28)

1. Jones R, Lydeard S: Irritable bowel syndrome in the general population. BMJ 1992, 304:87-90.
2. Hungin AP, Whorwell PJ, Tack J, Mearin F: The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003, 17:643-650.
3. Locke GR III. Talley NJ, Fett SL, et al.: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997, 112:1448-1456.
4. Agreus L, Svardsudd K, Talley NJ, et al.: Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population based study. Am J Gastroenterol 2001, 96:2905-2914.
5. Locke GR III, Zinsmeister AR, Fett SL, et al.: Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005, 17:29-34.
6. Pimentel M, Rossi F, Chow EJ, et al.: Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. J Clin Gastroenterol 2002, 23:221-224.
7. Locke GR III, Zinsmeister AR, Talley NJ, et al.: Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000, 75:907-912.
8. Kennedy TM, Jones RH, Hungin AP, et al.: Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998, 43:770-774.
9. Wong WM, Fass R: Extraesophageal and atypical manifestations of GERD. J Gastroenterol Hepatol 2004, 19(Suppl 3):S33-S43.
10. Talley NJ, Boyce P, Jones M: Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998, 42:690-695.
11. Smart HL, Nicholson DA, Atkinson M: Gastro-oesophageal reflux in the irritable bowel syndrome. Gut 1986, 27:1127-1131.
12. Guillemot F, Ducrotte P, Bueno L: Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice. Gastroenterol Clin Biol 2005, 29:243-246.
13. Stanghellini V, Armstrong D, Monnikes H. et al.: Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studies. Digestion 2005, 71:141-145.
14. Zimmerman J: Irritable bowel, smoking and oesophageal acid exposure: an insight into the nature of symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther 2004, 20:1297-1303.
15. Bardhan KD, Stanghellini V, Armstrong D, et al.: Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest. Digestion 2005, 69:229-237.
16. Bardhan KD, Stanghellini V, Armstrong D, et al.: International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004, 20:891-898.
17. Fass R, Stanghellini V, Monnikes H, et al.: Baseline analysis of symptom spectrum in GERD clinical trial patients: Results from the ReQuest database. Gastroenterology 2006, 130(4, Suppl 2):A-629, #W1075.
18. Talley NJ, Dennis EH, Schettler-Duncan VA: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003, 98:2454-2459.
19. Zimmerman J: Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms. Dig Dis Sci 2003, 48:743-749.
20. Papatheodoridis GV, Karamanolis DG: Prevalence and impact of upper and lower gastrointestinal symptoms in the Greek urban general population. Scand J Gastroenterol 2005, 40:412-421.
21. Raftopoulos Y, Papasavas P, Landreneau R: Clinical outcome of laparoscopic antireflux surgery for patients with irritable bowel syndrome. Surg Endosc 2004, 18:655-659.
22. Stanghellini V: ReQuest - the challenge of quantifying both esophageal and extra-esophageal manifestations of GERD. Best Pract Res Clin Gastroenterol 2004, 18(Suppl):27-30.
23. Nojkov B, Chey WD, Adlis S, Shaw M: Predictors of response to PPI therapy in patients with GERD: the influence of co-morbid IBS and psychological disease [abstract 416]. Gastroenterology 2005, 128:A61.
24. Fass R, Shapiro M, Dekel R, Sewell J: Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next? Aliment Pharmacol Ther 2005, 22:79-94.
25. Mertz H, Naliboff B, Munakata J, et al.: Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995, 109:40-52.
26. Trimble KS, Farouk R, Pryde A, et al.: Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci 1995, 40:1607-1613.
27. Costantini M, Sturniolo GC, Zaninotto G, et al.: Altered esophageal pain threshold in irritable bowel syndrome. Dig Dis Sci 1993, 38:206-212.
28. Dickman R, Fass R: Functional heartburn. Curr Treat Options Gastroenterol 2005, 8:285-291.